Viviane Sampaio Boaventura

Oswaldo Cruz Foundation (FIOCRUZ) - LIB and LEITV Laboratories

SCHOLARLY PAPERS

2

DOWNLOADS

479

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Vaccine Effectiveness of Two-Dose BNT162b2 Over Time Against COVID-19 Symptomatic Infection and Severe Cases Among Adolescents: Test Negative Design Case Control Studies in Brazil and Scotland

Number of pages: 23 Posted: 05 Apr 2022
Oswaldo Cruz Foundation (FIOCRUZ) - Center for Data and Knowledge Integration for Health (CIDACS), University of Edinburgh - Usher Institute, Oswaldo Cruz Foundation (FIOCRUZ) - LIB and LEITV Laboratories, University of Strathclyde - Department of Mathematics & Statistics, Oswaldo Cruz Foundation (FIOCRUZ) - Center for Data and Knowledge Integration for Health (CIDACS), Oswaldo Cruz Foundation (FIOCRUZ) - Center for Data and Knowledge Integration for Health (CIDACS), Oswaldo Cruz Foundation (FIOCRUZ) - Center for Data and Knowledge Integration for Health (CIDACS), Universidade de Brasília (UnB) - Tropical Medicine Centre, University of Glasgow - Institute of Health and Wellbeing, Oswaldo Cruz Foundation (FIOCRUZ) - LIB and LEITV Laboratories, Universidade do Estado do Rio de Janeiro (UERJ) - Instituto de Medicina Social, London School of Hygiene & Tropical Medicine, University of St. Andrews - School of Medicine, Government of the United Kingdom - Public Health Scotland, University of Aberdeen - Centre of Academic Primary Care, University of Edinburgh - Usher Institute of Population Health Sciences and Informatics, University of Edinburgh - Usher Institute, Oswaldo Cruz Foundation (FIOCRUZ) - Center for Data and Knowledge Integration for Health (CIDACS), University of Edinburgh - Edinburgh Clinical Trials Unit (ECTU), Oswaldo Cruz Foundation (FIOCRUZ) - Center for Data and Knowledge Integration for Health (CIDACS) and Oswaldo Cruz Foundation (FIOCRUZ) - Center for Data and Knowledge Integration for Health (CIDACS)
Downloads 282 (167,352)

Abstract:

Loading...

COVID-19-Severe cases, COVID-19-Symptomatic Infection, Vaccine effectiveness, adolescents

2.

Waning of mRNA Boosters after Homologous Primary Series with BNT162b2 or ChadOx1 Against Symptomatic Infection and Severe COVID-19 in Brazil and Scotland: A Test-Negative Design Case-Control Study

Number of pages: 25 Posted: 14 Apr 2022
Oswaldo Cruz Foundation (FIOCRUZ) - LIB and LEITV Laboratories, University of Edinburgh - Usher Institute, University of Strathclyde - Department of Mathematics & Statistics, Universidade de Brasília (UnB) - Tropical Medicine Centre, University of Glasgow - Institute of Health and Wellbeing, Oswaldo Cruz Foundation (FIOCRUZ) - Center for Data and Knowledge Integration for Health (CIDACS), Oswaldo Cruz Foundation (FIOCRUZ) - Center for Data and Knowledge Integration for Health (CIDACS), University of Edinburgh - Edinburgh Clinical Trials Unit (ECTU), Oswaldo Cruz Foundation (FIOCRUZ) - Center for Data and Knowledge Integration for Health (CIDACS), Universidade de Brasília (UnB) - Tropical Medicine Centre, London School of Hygiene & Tropical Medicine, Universidade do Estado do Rio de Janeiro (UERJ) - Instituto de Medicina Social, Oswaldo Cruz Foundation (FIOCRUZ) - Center for Data and Knowledge Integration for Health (CIDACS), Oswaldo Cruz Foundation (FIOCRUZ) - LIB and LEITV Laboratories, University of Edinburgh - Usher Institute and Oswaldo Cruz Foundation (FIOCRUZ) - Center for Data and Knowledge Integration for Health (CIDACS)
Downloads 197 (236,338)

Abstract:

Loading...

COVID-19, Vaccines, ChAdOx1, mRNA, booster, BNT162b2, Omicron, waning